| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 695032 | 112794001 | ADCETRIS 50 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | ADCETRIS 50 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 50 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/112794001/112794001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/112794001/112794001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 35004 | TAKEDA FARMACEUTICA ESPANA S.A. | 2012-11-29 | 1 | 1 | 1 | 2012-11-29 | 2012-11-29 | 1 | 2014-07-10 | View Edit Delete | ||||||||||||
| 700588 | 112795007 | FORXIGA 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | FORXIGA 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/112795007/112795007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/112795007/112795007_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34774 | ASTRAZENECA FARMACEUTICA SPAIN S.A. | 2012-11-23 | 1 | 1 | 1 | 2012-11-23 | 2015-04-17 | 1 | 2013-11-11 | 694777 | View Edit Delete | |||||||||||
| 695740 | 112797001 | EYLEA 40 MG/ML SOLUCION INYECTABLE EN JERINGA PRECARGADA | EYLEA 40 MG/ML SOLUCION INYECTABLE EN JERINGA PRECARGADA , 1 jeringa precargada de 90 microlitros | 3,6 mg inyectable 90 microlitros | 33 | 1 | 61 | 1 jeringa precargada de 90 microlitros | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/112797001/112797001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/112797001/112797001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 26523 | BAYER HISPANIA S.L. | 2012-12-21 | 1 | 1 | 1 | 2012-12-21 | 2012-12-21 | 1 | 2021-01-14 | View Edit Delete | ||||||||||||
| 695741 | 112797002 | EYLEA 40 MG/ML SOLUCION INYECTABLE EN VIAL | EYLEA 40 MG/ML SOLUCION INYECTABLE EN VIAL, 1 vial de 100 microlitros | 4 mg inyectable 100 microlitros | 45 | 1 | 34 | 1 vial de 100 microlitros | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/112797002/112797002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/112797002/112797002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 26523 | BAYER HISPANIA S.L. | 2012-12-21 | 1 | 1 | 1 | 2012-12-21 | 2012-12-21 | 1 | 2014-03-21 | View Edit Delete | ||||||||||||
| 764006 | 112797003 | EYLEA 114,3 MG/ML SOLUCION INYECTABLE | EYLEA 114,3 MG/ML SOLUCION INYECTABLE, 1 vial de 0,263 ml | 114, 3 mg/ml inyectable 0,263 ml | 45 | 1 | 34 | 1 vial de 0,263 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/112797003/112797003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/112797003/112797003_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 28087 | BAYER HISPANIA S.L. | 2024-01-09 | 1 | 1 | 1 | 2024-01-10 | 2024-01-09 | 1 | 2024-05-09 | View Edit Delete | ||||||||||||
| 765437 | 112797004 | EYLEA 114,3 MG/ML SOLUCION INYECTABLE EN JERINGA PRECARGADA | EYLEA 114,3 MG/ML SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 0,184 ml | 21 mg inyectable 184 microlitros | 33 | 1 | 61 | 1 jeringa precargada de 0,184 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/112797004/112797004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/112797004/112797004_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 28087 | BAYER HISPANIA S.L. | 2024-09-23 | 1 | 1 | 1 | 2024-09-24 | 2024-09-23 | 1 | 2024-12-05 | View Edit Delete | ||||||||||||
| 697254 | 112801002 | Constella 290 microgramos capsulas duras | Constella 290 microgramos capsulas duras Frasco con 28 cápsulas | 290 microgramos | 6 | 28 | 43 | Frasco con 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/112801002/112801002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/112801002/112801002_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41086 | ABBVIE SPAIN, S.L.U. | 2013-03-12 | 1 | 1 | 1 | 2013-03-12 | 2013-03-12 | 1 | 2014-05-24 | View Edit Delete | ||||||||||||
| 703505 | 112803002 | NEXOBRID 5 g polvo y gel para gel | NEXOBRID 5 g polvo y gel para gel 50 g | 5 g | 45 | 1 | 44 | 1 vial de 5g de polvo + 1 frasco de 50g de gel diluyente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/112803002/112803002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/112803002/112803002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 15672 | HAELSA PHARMA GMBH | 2014-09-15 | 1 | 1 | 1 | 2014-09-15 | 2014-09-15 | 1 | 2014-10-30 | View Edit Delete | ||||||||||||
| 697408 | 112807004 | TRESIBA 100 UNIDADES/ML FLEXTOUCH SOLUCION INYECTABLE EN PLUMA PRECARGADA | TRESIBA 100 UNIDADES/ML FLEXTOUCH SOLUCION INYECTABLE EN PLUMA PRECARGADA, 5 plumas precargadas de 3 ml | 100 U/ml inyectable 3 ml | 66 | 5 | 49 | 5 plumas precargadas de 3 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/112807004/112807004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/112807004/112807004_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1974 | NOVO NORDISK PHARMA S.A. | 2013-03-25 | 1 | 1 | 1 | 2013-03-25 | 2013-03-25 | 1 | 2015-11-30 | View Edit Delete | ||||||||||||
| 726213 | 112807013 | TRESIBA 200 UNIDADES/ML FLEXTOUCH SOLUCION INYECTABLE EN PLUMA PRECARGADA | TRESIBA 200 UNIDADES/ML FLEXTOUCH SOLUCION INYECTABLE EN PLUMA PRECARGADA, 3 plumas precargadas de 3 ml | 200 U/ml inyectable 3 ml | 66 | 3 | 49 | 3 plumas precargadas de 3 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/112807013/112807013_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/112807013/112807013_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1974 | NOVO NORDISK PHARMA S.A. | 2019-07-16 | 1 | 1 | 1 | 2019-07-17 | 2019-07-16 | 1 | 2019-12-13 | View Edit Delete | ||||||||||||
| 711117 | 112808009 | IMATINIB TEVA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | IMATINIB TEVA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos | 100 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/112808009/112808009_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/112808009/112808009_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 16041 | TEVA PHARMA S.L.U. | 2016-06-01 | 1 | 1 | 1 | 2016-06-02 | 2016-06-01 | 0 | 2016-11-14 | View Edit Delete | ||||||||||||
| 711116 | 112808018 | IMATINIB TEVA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | IMATINIB TEVA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 400 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/112808018/112808018_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/112808018/112808018_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 16041 | TEVA PHARMA S.L.U. | 2016-06-01 | 1 | 1 | 1 | 2016-06-02 | 2016-06-01 | 0 | 2016-11-14 | View Edit Delete | ||||||||||||
| 696527 | 112809010 | BETMIGA 50mg comprimidos de liberacion prolongada | BETMIGA 50mg comprimidos de liberacion prolongada, 30 comprimidos | 50 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/112809010/112809010_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/112809010/112809010_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13990 | ASTELLAS PHARMA S.A. | 2013-02-01 | 1 | 1 | 1 | 2013-02-01 | 2013-02-01 | 1 | 2014-03-20 | View Edit Delete | ||||||||||||
| 701257 | 112812001 | BEXSERO SUSPENSION INYECTABLE EN JERINGA PRECARGADA | BEXSERO SUSPENSION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada con aguja | N/A (Vacuna) | 33 | 1 | 61 | 1 jeringa precargada con aguja | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/112812001/112812001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/112812001/112812001_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 19738 | GLAXOSMITHKLINE S.A. | 2014-01-27 | 1 | 1 | 1 | 2014-01-27 | 2014-01-27 | 1 | 2014-08-21 | View Edit Delete | ||||||||||||
| 696947 | 112814001 | ZALTRAP 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | ZALTRAP 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 4 ml | 25 mg/ml inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/112814001/112814001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/112814001/112814001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41749 | SANOFI AVENTIS S.A. | 2013-02-22 | 1 | 1 | 1 | 2013-02-22 | 2013-02-22 | 1 | 2013-09-02 | View Edit Delete | ||||||||||||
| 696952 | 112814003 | ZALTRAP 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | ZALTRAP 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 8 ml | 25 mg/ml inyectable 8 ml | 45 | 1 | 34 | 1 vial de 8 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/112814003/112814003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/112814003/112814003_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41749 | SANOFI AVENTIS S.A. | 2013-02-22 | 1 | 1 | 1 | 2013-02-22 | 2013-02-22 | 1 | 2013-09-02 | View Edit Delete | ||||||||||||
| 697871 | 112815002 | SELINCRO 18 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | SELINCRO 18 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 14 comprimidos recubiertos con pelicula | 18 mg | 5 | 14 | 10 | 14 comprimidos recubiertos con pelicula | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/112815002/112815002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/112815002/112815002_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1250 | LUNDBECK ESPANA S.A. | 2013-04-30 | 1 | 1 | 1 | 2013-04-30 | 2013-04-30 | 1 | 2014-06-12 | View Edit Delete | ||||||||||||
| 701018 | 112869001 | LEMTRADA 12 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | LEMTRADA 12 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 1,2 ml | 12 mg | 45 | 1 | 34 | 1 vial de 1,2 ml | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/112869001/112869001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/112869001/112869001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27935 | SANOFI AVENTIS S.A. | 2013-12-20 | 1 | 1 | 1 | 2013-12-20 | 2013-12-20 | 1 | 2015-02-12 | View Edit Delete | ||||||||||||
| 731499 | 1130829002 | HEXYON SUSPENSION INYECTABLE EN JERINGA PRECARGADA | HEXYON SUSPENSION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada (sin aguja) | N/A (vacuna) | 33 | 1 | 61 | 1 jeringa precargada (sin aguja) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1130829002/1130829002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1130829002/1130829002_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41749 | SANOFI AVENTIS S.A. | 2021-08-16 | 1 | 1 | 1 | 2021-08-17 | 2021-08-16 | 1 | 2022-01-10 | View Edit Delete | ||||||||||||
| 765355 | 1130829002 | HEXYON SUSPENSION INYECTABLE EN JERINGA PRECARGADA | HEXYON SUSPENSION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada + 1 aguja de seguridad | N/A (vacuna) | 33 | 1 | 61 | 1 jeringa precargada + 1 aguja de seguridad | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1130829002/1130829002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1130829002/1130829002_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41749 | SANOFI AVENTIS S.A. | 2021-08-16 | 1 | 1 | 1 | 2021-08-17 | 2024-07-11 | 1 | 2025-08-28 | View Edit Delete |
Page 61 of 1036, showing 20 records out of 20708 total, starting on record 1201, ending on 1220